In vitro anti‐trypanosomal activity of synthetic nitrofurantoin‐triazole hybrids against Trypanosoma species causing human African trypanosomosis

Author:

Seetsi Anna1,N'da David D.2,Molefe‐Nyembe Nthatisi3,Suganuma Keisuke4,Ramatla Tsepo1ORCID,Thekisoe Oriel1

Affiliation:

1. Unit for Environmental Sciences and Management North‐West University Potchefstroom South Africa

2. Centre of Excellence for Pharmaceutical Sciences (PHARMACEN) North‐West University Potchefstroom South Africa

3. Department of Zoology and Entomology University of the Free State Phuthaditjhaba South Africa

4. OIE Reference Laboratory for Surra, National Research Center for Protozoan Diseases Obihiro University of Agriculture and Veterinary Medicine Obihiro Hokkaido Japan

Abstract

AbstractHuman African trypanosomosis (HAT) which is also known as sleeping sickness is caused by Trypanosoma brucei gambiense that is endemic in western and central Africa and T. b. rhodesiense that is endemic in eastern and southern Africa. Drugs used for treatment against HAT first stage have limited effectiveness, and the second stage drugs have been reported to be toxic, expensive, and have time‐consuming administration, and parasitic resistance has developed against these drugs. The aim of this study was to evaluate the anti‐trypanosomal activity of nitrofurantoin‐triazole hybrids against T. b. gambiense and T. b. rhodesiense parasites in vitro. This study screened 19 synthesized nitrofurantoin‐triazole (NFT) hybrids on two strains of human trypanosomes, and cytotoxicity was evaluated on Madin‐Darby bovine kidney (MDBK) cells. The findings in this study showed that an increase in the chain length and the number of carbon atoms in some n‐alkyl hybrids influenced the increase in anti‐trypanosomal activity against T. b. gambiense and T. b. rhodesiense. The short‐chain n‐alkyl hybrids showed decreased activity compared to the long‐chain n‐alkyl hybrids, with increased activity against both T. b. gambiense and T. b. rhodesiense. Incorporation of additional electron‐donating substituents in some NFT hybrids showed increased anti‐trypanosomal activity than to electron‐withdrawing substituents in NFT hybrids. All 19 NFT hybrids tested displayed better anti‐trypanosomal activity against T. b. gambiense than T. b. rhodesiense. The NFT hybrid no. 16 was among the best performing hybrids against both T. b. gambiense (0.08 ± 0.04 μM) and T. b.rhodesiense (0.11 ± 0.06 μM), and its activity might be influenced by the introduction of fluorine in the para‐position on the benzyl ring. Remarkably, the NFT hybrids in this study displayed weak to moderate cytotoxicity on MDBK cells. All of the NFT hybrids in this study had selectivity index values ranging from 18 to greater than 915, meaning that they were up to 10–100 times fold selective in their anti‐trypanosomal activity. The synthesized NFT hybrids showed strong selectivity >10 to T. b. gambiense and T. b. rhodesiense, which indicates that they qualify from the initial selection criteria for potential hit drugs.

Funder

Japan Society for the Promotion of Science

National Research Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3